SCOPUS 정보 검색 플랫폼

Volumn 50, Issue 6, 1999, Pages 395-397

As;Aktuelle Stellungnahme der Arbeitsgemeinschaft Dermatologische Onkologie zur Hochdosistherapie mit Interferon α2b Kommission Klinische Studien der ADO Fürdie "Kommission Klinische Studien der ADO"

(1) Hauschild, A a

a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004186631 PISSN: 00178470 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (3)

References (8)

1
- 0032585283
- Fatality and Interferon alpha for malignant melanoma
- Carson JJ, Gold LH, Barton AB, Biss RT (1998) Fatality and Interferon alpha for malignant melanoma. Lancet 352:1443-1444
- (1998) Lancet , vol.352 , pp. 1443-1444
- Carson, J.J.¹ Gold, L.H.² Barton, A.B.³ Biss, R.T.⁴

2
- 7144228601
- Randomised trial of Interferon alpha-2b as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases
- French Cooperative Group on Melanoma
- Grob JJ, Dreno B, dela Salmoniere P, Delaunay M, Cupissol D, Guillot B, Souteyrand P, Sassolas B, Cesarini JP, Lionnet S, Lok C, Chasting C, Bonerandi JJ (1998) Randomised trial of Interferon alpha-2b as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma. Lancet 351:1905-1910
- (1998) Lancet , vol.351 , pp. 1905-1910
- Dreno B, G.J.J.¹ Dela Salmoniere, P.² Delaunay, M.³ Cupissol, D.⁴ Guillot, B.⁵ Souteyrand, P.⁶ Sassolas, B.⁷ Cesarini, J.P.⁸ Lionnet, S.⁹ Lok, C.¹⁰ Chasting, C.¹¹ Bonerandi, J.J.¹²

3
- 0031924123
- Adjuvante Interferon-α-Therapie beim Melanom. Stellungnahme der Arbeitsgemeinschaft Dermatologische Onkologie (ADO)
- Hauschild A, Dummer R, Garbe C, Kaufmann R, Schadendorf D, Soyer HP, Stadler R,Tilgen W (1998) Adjuvante Interferon-α-Therapie beim Melanom. Stellungnahme der Arbeitsgemeinschaft Dermatologische Onkologie (ADO). Hautarzt 49:167-169
- (1998) Hautarzt , vol.49 , pp. 167-169
- Hauschild, A.¹ Dummer, R.² Garbe, C.³ Kaufmann, R.⁴ Schadendorf, D.⁵ Soyer, H.P.⁶ Stadler, R.⁷ Tilgen, W.⁸

4
- 0030030347
- Interferon-α2b adjuvant therapy of highrisk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
- Kirkwood JM, Strawderman MH, Ernsthoff MS, Smith TJ, Borden EC, Blum RH (1996) Interferon-α2b adjuvant therapy of highrisk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17
- (1996) J Clin Oncol , vol.14 , pp. 7-17
- Kirkwood, J.M.¹ Strawderman, M.H.² Ernsthoff, M.S.³ Smith, T.J.⁴ Borden, E.C.⁵ Blum, R.H.⁶

5
- 0032572127
- Adjuvant IFN alpha 2 therapy of melanoma
- Kirkwood JM (1998) Adjuvant IFN alpha 2 therapy of melanoma. Lancet 351:1901-1903
- (1998) Lancet , vol.351 , pp. 1901-1903
- Kirkwood, J.M.¹

6
- 0345363700
- Role of high-dose IFN in high-risk melanoma: Preliminary results of the E1690/C9190 US Intergroup post-operative adjuvant trial of high-and low-dose IFNα2b(HDI and LDI) in resected high-risk primary or regionally lymph node metastatic melanoma in relation to 10-year updated results of E1690
- Athen, November 1998
- Kirkwood JM, Ibrahim J, Sondak J, Ernsthoff M, Flaherty L, Smith T, Richards J, Rao U, Steele M, Blum R (1998) Role of high-dose IFN in high-risk melanoma: preliminary results of the E1690/C9190 US Intergroup post-operative adjuvant trial of high-and low-dose IFNα2b(HDI and LDI) in resected high-risk primary or regionally lymph node metastatic melanoma in relation to 10-year updated results of E1690. Abstract of the Annual Congress of the European Society for Medical Oncology. Athen, November 1998
- (1998) Abstract of the Annual Congress of the European Society for Medical Oncology
- Kirkwood, J.M.¹ Ibrahim, J.² Sondak, J.³ Ernsthoff, M.⁴ Flaherty, L.⁵ Smith, T.⁶ Richards, J.⁷ Rao, U.⁸ Steele, M.⁹ Blum, R.¹⁰

7
- 7144264391
- Adjuvant Interferon-α2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group
- Pehamberger H, Soyer HP, Steiner A, Kofler R, Binder M, Mischer P, Pachinger W, Auboeck J, Fritsch P, Kerl H, Wolff K (1998) Adjuvant Interferon-α2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol 16:1425-1429
- (1998) J Clin Oncol , vol.16 , pp. 1425-1429
- Pehamberger, H.¹ Soyer, H.P.² Steiner, A.³ Kofler, R.⁴ Binder, M.⁵ Mischer, P.⁶ Pachinger, W.⁷ Auboeck, J.⁸ Fritsch, P.⁹ Kerl, H.¹⁰ Wolff, K.¹¹

8
- 0031049344
- Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interon alpha in malignant melanoma
- Reinhold U, Harl C, Hering R, Hoeft A, Kreysel HW (1997) Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interon alpha in malignant melanoma. Lancet 349:540-541
- (1997) Lancet , vol.349 , pp. 540-541
- Reinhold, U.¹ Harl, C.² Hering, R.³ Hoeft, A.⁴ Kreysel, H.W.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.